Sentence examples for identification of leads from inspiring English sources

Currently, the identification of leads is still a random process relying largely on expert knowledge.

Using this methodology a library of N-substituted analogues were prepared for the rapid identification of leads with the potential to be fast onset and long-acting inhaled bronchodilators with improved therapeutic margins.

This review focuses on the peptidomimetic developments in this area, as well as the concept of tailoring structural and functional diversity in a library using carbohydrate scaffolds and how this can lead to increased hit rates and rapid identification of leads, which has promising prospects for drug development.

Here, we focus on the emergence of label-free biosensors with throughput capabilities orders of magnitude higher than the previous state-of-the-art, which can facilitate large assays such as epitope binning so that they can be incorporated alongside functional activity screens, enabling the rapid identification of leads that exhibit unique and functional epitopes.

Examples of campaigns on social media that have succeeded through identification of leads and direct interaction with online users span the education industry, entertainment, small business and many other 'viral marketing' settings.

De novo drug design has emerged as a valuable concept for the rapid identification of lead structure candidates.

In this paper, an adaptation method for the online identification of lead time is incorporated in production inventory control systems.

This strategy led to the identification of lead compound 9 with enhanced enzyme and cellular potency, while maintaining good selectivity over a number of kinases.

In this study, we have addressed the question whether the modified Rossmann fold in 17βHSD1 is a target for identification of lead compounds for structure-based drug design.

They provide the detail necessary for the structure-based design and identification of lead compounds with potential as PTP-specific drugs for therapeutic use.

The topic is also discussed in regard to recent steps undertaken in glycobiology toward identification of lead candidates using microarrays and modern analytical tools.